Cumulative Corticosteroid Dose Over Fifty‐Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials

OBJECTIVE: To examine the effects of treatment with belimumab on corticosteroid dose in patients with systemic lupus erythematosus (SLE) over 52 weeks in 2 randomized, controlled trials. METHODS: Data on patients who were taking corticosteroids at baseline in the Study of Belimumab in Subjects with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arthritis Rheumatol
Egile Nagusiak: van Vollenhoven, Ronald F., Petri, Michelle, Wallace, Daniel J., Roth, David A., Molta, Charles T., Hammer, Anne E., Tang, Yongqiang, Thompson, April
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2016
Gaiak:
Systemic Lupus Erythematosus
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129492/
https://ncbi.nlm.nih.gov/pubmed/26992106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39682
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak